Search Results - "O'Hare, Jolyne"

Clinicoradiological outcomes after radical radiotherapy for lung cancer in patients with interstitial lung disease by Walls, Gerard M, McMahon, Michael, Moore, Natasha, Nicol, Patrick, Bradley, Gemma, Whitten, Glenn, Young, Linda, O'Hare, Jolyne M, Lindsay, John, Connolly, Ryan, Linden, Dermot, Ball, Peter A, Hanna, Gerard G, McAleese, Jonathan

“…Interstitial lung disease (ILD) is relatively common in patients with lung cancer with an incidence of 7.5%. Historically pre-existing ILD was a…”
Get full text

Coincidental splenic irradiation and risk of functional hyposplenism in oesophageal cancer treatment by Ellis, Rachel, Cole, Aidan J, O’Hare, Jolyne, Whitten, Glenn, Crowther, Karen, Harrison, Claire

“…Introduction Definitive chemoradiotherapy (dCRT) and radical radiotherapy are central to the management of distal oesophageal carcinoma. This study sought to…”
Get full text

Laryngeal tumours and radiotherapy dose to the cricopharyngeus are predictive of death from aspiration pneumonia by O’Hare, Jolyne, Maclean, Julia, Szczesniak, Michal, Gupta, Rashmi, Wu, Peter, Quon, Harry, Cook, Ian, Graham, Peter

“…Highlights • Aspiration pneumonia is a leading cause of mortality following head and neck cancer radiotherapy. • Risk factors that increase this mortality…”
Get full text

3130: Impact of appropriate staging on radiotherapy planning for radical radiotherapy for lung cancer by Young, Linda, Toland, Niamh, Baluch, Suhail, O'Hare, Jolyne, Crockett, Cathryn, Tumelty, Karen, Walls, Gerard M., McAleese, Jonathan, Hanna, Gerard G.

Get full text

2073: Outcomes following SABR for early-stage NSCLC in patients with interstitial lung disease (ILD) by Quigley, David, Johnston, David, Crockett, Cathryn, O'Hare, Jolyne, Young, Linda, Tumelty, Karen, Hanna, Gerard G., McAleese, Jonathan

Get full text

156 Increasing re-planning rates for radical lung radiotherapy – the role of frequent cone beam IGRT and tumour size by Kearney, Bernard, Hanna, Gerry G, Crockett, Cathryn, O'Hare, Jolyne, Tumelty, Karen, Walls, Gerard, McAleese, Jonathan, Young, Linda

Get full text

144 Reducing the risk of death from PJP after radical lung cancer radiotherapy – second round QI intervention updated with early outcome data by Leer, Martin, Tee, Jin, Tumelty, Karen, Crockett, Cathryn, O'Hare, Jolyne, Hanna, Gerard G, McAleese, Jonathan, Young, Linda

Get full text

155 Advanced Practice Clinical technologist contouring GTV volumes for radical lung radiotherapy by Black, Sarah Louise, Nelson, Catherine, McAleese, Jonathan, Hanna, Gerry G, Crockett, Cathryn, Tumelty, Karen, Walls, Gerard, O'Hare, Jolyne, Young, Linda, O'Shea, Pat

Get full text

Hypofractionated radiotherapy to the pancreas: U.K. experience by Teoh, Suliana, Sabbagh, Ahmad, Wadsley, Jonathan, Low, Lori, Harrison, Claire, O'Hare, Jolyne, Goody, Rebecca, Summers, Kitty, Wilson, David, Walther, Julie, Wilson, Fiona, Radhakrishna, Ganesh, Aitken, Katharine, Owens, Rob, Mukherjee, Somnath

“…Abstract only 525 Background: During the COVID19 pandemic, many centres in the UK, shifted towards utilising hypofractionated radiotherapy (RT) to pancreas. We…”
Get full text

A pulmonary vein atlas for radiotherapy planning by Walls, Gerard M, McCann, Conor, Ball, Peter, Atkins, Katelyn M, Mak, Raymond H, Bedair, Ahmed, O'Hare, Jolyne, McAleese, Jonathan, Harrison, Claire, Tumelty, Karen A, Crockett, Cathryn, Black, Sarah-Louise, Nelson, Catherine, O'Connor, John, Hounsell, Alan R, McGarry, Conor K, Butterworth, Karl T, Cole, Aidan J, Jain, Suneil, Hanna, Gerard G

“…•intrathoracic radiation is associated with short- and medium-term cardiac events.•conduction abnormalities such as AF are common after lung/oesophageal…”
Get full text

Quantitative Evaluation of Head and Neck Cancer Treatment–Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm by Quon, Harry, Hui, Xuan, Cheng, Zhi, Robertson, Scott, Peng, Luke, Bowers, Michael, Moore, Joseph, Choflet, Amanda, Thompson, Alex, Muse, Mariah, Kiess, Ana, Page, Brandi, Fakhry, Carole, Gourin, Christine, O'Hare, Jolyne, Graham, Peter, Szczesniak, Michal, Maclean, Julia, Cook, Ian, McNutt, Todd

“…To test the hypothesis that quantifying swallow function with multiple patient-reported outcome (PRO) instruments is an important strategy to yield insights in…”
Get full text

444 Direct Versus Indirect Methods for Detecting Pharyngeal Outflow Obstruction in Dysphagia Following Head and Neck Cancer by Wu, Peter, Szczesniak, Michal, Julia, Maclean, Quon, Harry, O'Hare, Jolyne, Graham, Peter, Choo, Lennart, Zhang, Teng G, Omari, Taher, Cook, Ian J

Get full text

Bicalutamide (150 mg) monotherapy versus LHRHa as neoadjuvant treatment in intermediate- and high-risk prostate cancer: A case matched study by Mitchell, Darren M., McDowell, Cliona, McGivern, Ursula, Corey, Gemma, O'Hare, Jolyne, O'Sullivan, Joe M.

“…Abstract only 226 Background: The role of neo-adjuvant Lutenising Hormone Releasing Hormone Agonist (LHRHa) therapy prior to radical radiotherapy of…”
Get full text

Neoadjuvant hormone therapy for radical prostate radiotherapy: A case-matched study comparing bicalutamide to LHRH agonist therapy by O'Hare, Jolyne, McGivern, Ursula, McDowell, Cliona, Mitchell, Darren M., Corey, Gemma, O'Sullivan, Joe M.

“…Abstract only 88 Background: To assess and compare the biochemical failure free survival (BFFS), PSA kinetics and absolute PSA responses in men receiving…”
Get full text

Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia by Hau, Eric, Hegi‐Johnson, Fiona, Atkinson, Charlotte, Barber, Jeffrey, Browne, Lois H, Chin, Yaw, Dwyer, Patrick, Graham, Peter H, O'Hare, Jolyne, Lu, Dan, Rains, Melissa, Ragusa, Carolina, Schmidth, Laurel, Small, Katherine, Unicomb, Kylie, West, Katrina, White, Sean, Last, Andrew, Ludbrook, Jane, Azzi, Maria, Aherne, Noel J, Van Tilburg, Kevin, Vinod, Shalini, Ma, Xiaobing, Yeghiaian Alvandi, Roland

“…Introduction Stereotactic ablative radiotherapy (SABR) for lung cancer is a modality of treatment that has improved outcomes for lung cancer patients. However,…”
Get full text

113 - Toxicity rates of accelerated concurrent chemoradiation for NSCLC and access to durvalumab at a UK cancer centre by Tee, Jin Howe, O’Hare, Jolyne, Hanna, Gerard, McAleese, Jonathan

Get full text

Toxicity rates of accelerated concurrent chemoradiation for NSCLC and access to durvalumab at a UK cancer centre by Tee, Jin Howe, O’Hare, Jolyne, Hanna, Gerard, McAleese, Jonathan

Get full text

Neoadjuvant Hormone Therapy for Radical Prostate Radiotherapy: Bicalutamide Monotherapy vs. Luteinizing Hormone–Releasing Hormone Agonist Monotherapy: A Single-Institution Matched-Pair Analysis by McGivern, Ursula, Mitchell, Darren M, McDowell, Cliona, O'Hare, Jolyne, Corey, Gemma, O'Sullivan, Joe M

“…Micro-Abstract This study was an analysis of prostate-specific antigen (PSA) kinetics and the response in a case-matched cohort of men treated with either…”
Get full text

Importance of the spleen as an OAR in left sided lung cancers: audit and recommendations by Hill, Nicola, Whitten, Glenn, Evans, Rhun, Tee, Jin, Tumelty, Karen, McAleese, Jonathan, O’Hare, Jolyne

Get full text

Using oxygen therapy in the palliative care setting by Goody, R, O'Hare, J, Watson, M

“…The use of oxygen therapy to treat breathlessness in terminally ill patients. Criteria for use, contraindications and issues to consider before initiation are…”
Get full text